Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimization of Darunavir Therapy Through Population Pharmacokinetic Modeling, Simulations and Dosage Guidelines

NCT03101644 is registered in ClinicalTrials.gov with Université Catholique de Louvain as lead sponsor.

NCT NCT03101644
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03101644 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimization of Darunavir Therapy Through Population Pharmacokinetic Modeling, Simulations and Dosage Guidelines
Lead sponsor
Université Catholique de Louvain
Phase
Phase 4
Overall status
Completed
Start date
March 23, 2017
Completion date
June 12, 2019
Enrollment
127 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

human immunodeficiency virus i infection